» Articles » PMID: 29501082

A Shift to Glycolysis Accompanies the Inflammatory Changes in PBMCs from Individuals with an IQ-discrepant Memory

Overview
Journal J Neuroimmunol
Specialty Neurology
Date 2018 Mar 5
PMID 29501082
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Identification of a blood-based biomarker that can detect early cognitive decline presents a significant healthcare challenge. We prepared peripheral blood mononuclear cells (PBMCs) from individuals who had a poorer than predicted performance in their delayed recall performance on the Logical Memory II Subtest of the Wechsler Memory Scale (WMS) relative to their IQ estimated by the National Adult Reading Test (NART); we described these individuals as IQ-discrepant, compared with IQ-consistent, individuals. Stimulation with Aβ + LPS increased production of TNFα to a greater extent in cells from IQ-discrepant, compared with IQ-consistent, individuals. This was associated with a shift towards glycolysis and the evidence indicates that 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase (PFKFB)3 plays a role in driving glycolysis. A similar shift towards glycolysis was observed in MDMs prepared from IQ-discrepant, compared with IQ-consistent, individuals. The important finding here is that we have established an increased sensitivity to Aβ + LPS stimulation in PBMCs from individuals that under-perform on a memory task, relative to their estimated premorbid IQ, which may be an indicator of early cognitive decline. This may be a useful tool in determining the presence of early cognitive dysfunction.

Citing Articles

Increased mitochondrial proton leak and glycolysis in peripheral blood mononuclear cells in type-1-diabetes.

Mendes Lopes de Melo J, Laursen J, Sondergaard-Heinrich N, Rasmussen I, Hansen C, Frimodt-Moller M Heliyon. 2023; 8(12):e12304.

PMID: 36593831 PMC: 9803776. DOI: 10.1016/j.heliyon.2022.e12304.


Neuropsychological decrements in midlife type-2 diabetes are not associated with peripheral NLRP3 inflammasome responsiveness.

Dyer A, Batten I, Reddy C, Townsend L, Woods C, ONeill D Front Immunol. 2022; 13:1021351.

PMID: 36311713 PMC: 9607906. DOI: 10.3389/fimmu.2022.1021351.


Inhibition of PFKFB3 suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss.

Wang J, Guan H, Liu H, Lei Z, Kang H, Guo Q J Cell Mol Med. 2019; 24(3):2294-2307.

PMID: 31880389 PMC: 7011148. DOI: 10.1111/jcmm.14912.